DBD vs EVCM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

DBD

36.2
AI Score
VS
EVCM Wins

EVCM

42.4
AI Score

Investment Advisor Scores

DBD

36score
Recommendation
AVOID NEW MONEY

EVCM

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DBD EVCM Winner
Forward P/E 12.1655 11.0742 EVCM
PEG Ratio 0 0.3691 Tie
Revenue Growth 1.7% 2.7% EVCM
Earnings Growth 34.2% 16.3% DBD
Tradestie Score 36.2/100 42.4/100 EVCM
Profit Margin 2.9% 5.7% EVCM
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD EVCM

Relative Price Performance (Last 90 Days)

DBD 1M: +5.9% · 3M: -21.6% EVCM 1M: +14.6% · 3M: -16.5%

Current Technical Phase

DBD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 60.3 · Price: $68.16

EVCM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.8 · Price: $9.24

Fundamentals Snapshot

Metric DBD EVCM
Market Cap — —
Forward P/E 9.7 11.7
Trailing P/E 22.4 61.1
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.8%
Operating Margin 0.1% 0.1%
EPS 3.03 0.15
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, EVCM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.